SLE‐associated myelitis successfully treated by rituximab

Systemic lupus erythematosus (SLE) is an autoimmune disease. Transverse myelitis (TM) is one of the rare neurological manifestations of SLE. Here, we present a case of SLE in which TM precede other symptoms and successfully treated by Rituximab.

Detalles Bibliográficos
Autores principales: Khabbazi, Alireza, Ghadakchi, Leyla, Yazdani, Yalda, Habibzade, Elham, Mehrtabar, Saba, Khalaji, Amirreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676124/
https://www.ncbi.nlm.nih.gov/pubmed/36419577
http://dx.doi.org/10.1002/ccr3.6622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676124/
https://www.ncbi.nlm.nih.gov/pubmed/36419577
http://dx.doi.org/10.1002/ccr3.6622

Ejemplares similares